TheraRadar
← Back
Data updated: Jun 28, 2026

NIH NCI DCTD

Pharma
Pharmaceuticals

NIH NCI DCTD is a pharmaceutical company with 1 FDA-approved products.

2011
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

NIH NCI DCTD's Key Drugs

NIH NCI DCTD's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

NIH NCI DCTD's Recent FDA Approvals

New NDA/BLA approvals for NIH NCI DCTD over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

NIH NCI DCTD's Therapeutic Areas

Disease areas where NIH NCI DCTD has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

NIH NCI DCTD Pipeline Snapshot

Active clinical trials for NIH NCI DCTD across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling